Atara Biotherapeutics
ATRA
#9994
Rank
HK$0.59 B
Marketcap
HK$66.28
Share price
2.42%
Change (1 day)
-22.95%
Change (1 year)

Revenue for Atara Biotherapeutics (ATRA)

Revenue in 2026 (TTM): HK$0.18 Billion

According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM ) is HK$0.18 Billion. In 2025 the company made a revenue of HK$0.93 Billion a decrease over the revenue in the year 2024 that were of HK$1.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atara Biotherapeutics from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) HK$0.18 B-80.71%
2025 HK$0.93 B-6.13%
2024 HK$1.00 B1395.06%
2023 HK$66.95 M-86.52%
2022 HK$0.49 B213.18%
2021 HK$0.15 B
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ImmunoGen
IMGN
HK$2.25 B 1,142.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.97 B 435.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
HK$7.54 M-95.84%๐Ÿ‡ฉ๐Ÿ‡ช Germany